Secondary cytoreduction in epithelial ovarian cancer

Crit Rev Oncol Hematol. 1995 Jan;18(1):1-8. doi: 10.1016/1040-8428(94)00111-6.
No abstract available

Publication types

  • Review

MeSH terms

  • Actuarial Analysis
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use
  • Chemotherapy, Adjuvant
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Female
  • Humans
  • Infusions, Parenteral
  • Laparotomy
  • Multicenter Studies as Topic
  • Neoplasm Recurrence, Local
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / mortality
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / radiotherapy
  • Ovarian Neoplasms / surgery
  • Ovarian Neoplasms / therapy*
  • Phosphorus Radioisotopes / therapeutic use
  • Radiotherapy, Adjuvant
  • Randomized Controlled Trials as Topic
  • Reoperation
  • Salvage Therapy*
  • Survival Analysis
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Phosphorus Radioisotopes